🇺🇸 FDA

Drug profile · INN

emedastine difumarate

EMADINE

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

emedastine difumarate (EMADINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN emedastine difumarate
Brand EMADINE
Route OPHTHALMIC
Formulation SOLUTION/DROPS

Frequently asked questions

What is emedastine difumarate?

emedastine difumarate (EMADINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for emedastine difumarate?

EMADINE is a marketed brand name for emedastine difumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of emedastine difumarate?

emedastine difumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.